Grifols Stock News

Image source: The Motley Fool. Repro-Med Systems, or KORU Medical Systems (NASDAQ: KRMD)Q1 2020 Earnings CallMay 05, 2020, 9:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call Partic

Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), a leading global producer of plasma-derived medicines and a leader in the development of innovative diagnostic solutions, today announced that it has r

Grifols (MCE:GRF, MCE:GRF.P NASDAQ:GRFS), a leading global producer of plasma-derived medicines, today announced the launch of a new 3-mL (900-IU) vial for HyperRAB (rabies immune globulin [human]), a

GRFS vs. ZTS: Which Stock Is the Better Value Option?

Altium Wealth Management LLC acquired a new stake in shares of GRIFOLS S A/S (NASDAQ:GRFS) in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange C

Ladenburg Thalmann Financial Services Inc. decreased its position in shares of GRIFOLS S A/S (NASDAQ:GRFS) by 46.8% in the 4th quarter, according to the company in its most recent disclosure with the

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was

While the world battles the COVID-19 pandemic, a drugmaker with a massive presence in North Carolina is looking for recovered COVID-19 patients to donate plasma toward the cause – and if successful,

Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company with a track record of more than 100 years and a recognized leader in the development and production of plasma-derived medicines,

Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...